advertisement
11.3.4 Betablocker (15)
Showing records 1 to 15
Display all abstracts in classification 11.3.4 Betablocker
Search within classification 11.3.4 Betablocker3608 Brimonidine 0.2% as a replacement for beta blockers in geriatric patients with glaucoma
Noecker RJ; Cantor L; Katz J; Katzman B; Kent A; LeBlanc R; Severin T
Advances in Therapy 2002; 19: 91-97
3609 Cardiovascular effects of timolol maleate, brimonidine or brimonidine/timolol maleate in concomitant therapy
Stewart WC; Stewart JA; Jackson AL
Acta Ophthalmologica Scandinavica 2002; 80: 277-281
3612 Clinical research on 0.2% alphagan and 0.5% timolol in primary open-angle glaucoma and ocular hypertension
Zhong L; Li M
Chinese Ophthalmic Research 2002; 20: 153-156
3613 Comparison of the neuroprotective effects of adrenoceptor drugs in retinal cell culture and intact retina
Baptiste DC; Hartwick ATE; Jollimore CAB; Baldridge WH; Chauhan BC; Tremblay F; Kelly MEM
Investigative Ophthalmology and Visual Science 2002; 43: 2666-2676
3614 Comparison of latanoprost monotherapy with timolol-dorzolamide combination in patients with open-angle glaucoma or ocular hypertensio
Bron A; European latanoprost study group; European Latanoprost Study Group
Journal Français d'Ophtalmologie 2002; 25: 604-8
3615 Determination of betaxolol in human aqueous humour by high-performance liquid chromatography with fluorescence detection
Dulger B; Basci NE; Sagdic Yalvac I; Temizer A
Journal of Chromatography. B. Analyt Technol Biomed Life Sciences 2002; 772: 179-183
3616 A comparison of the efficacy and tolerability of 0.5% timolol maleate ophthalmic gel-forming solution QD and 0.5% levobunolol hydrochloride BID in patients with ocular hypertension or open-angle glaucoma
Halper LK; Johnson Pratt L; Dobbins T; Hartenbaum D
Journal of Ocular Pharmacology and Therapeutics 2002; 18: 105-113
3617 Latanoprost and timolol combination therapy versus monotherapy: one-year randomized trial
Higginbotham EJ; Feldman R; Stiles M; DuBiner H
Archives of Ophthalmology 2002; 120: 915-922
3618 Effect of betaxolol on impaired choroidal blood flow after intravitreal injection of endothelin-1 in albino rabbits
Kim JH; Kim DM; Park WC
Journal of Ocular Pharmacology and Therapeutics 2002; 18: 203-209
3619 A comparison of once-daily morning versus evening dosing of concomitant latanoprost/timolol
Konstas AGP; Nakos E; Tersis I; Lallos NA; Leech JN; Stewart WC
American Journal of Ophthalmology 2002; 133: 753-757
3620 Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops
Korte JM; Kaila T; Saari KM
Graefe's Archive for Clinical and Experimental Ophthalmology 2002; 240: 430-435
3621 Additive effect of topical nipradilol for normal-tension glaucoma treated by unoprostone or latanoprost
Mizutani M; Takeuchi A; Koike N; Hisada Y; Suga Y; Isokawa H; Nakamura Y; Miyake G; Saito Y; Iwaki M
Japanese Journal of Clinical Ophthalmology 2002; 56: 799-803
3622 A multicenter evaluation on the additive effect of nipradilol ophthalmic solution
Nakagawa T; Takahashi T; Saie T; Araki H; Takei A; Yui A; Tachibana N; Kimura T; Kanai A
Japanese Journal of Clinical Ophthalmology 2002; 56: 355-360
3623 Comparison of the cardiovascular effects of unoprostone 0.15%, timolol 0.5% and placebo in healthy adults during exercise using a treadmill test
Stewart WC; Stewart JA; Crockett S; Kubilus C; Brown A; Shams N
Acta Ophthalmologica Scandinavica 2002; 80: 272-276
3624 Effects of latanoprost, prostaglandin F2α and nipradilol on isolated bovine ciliary muscle
Yoshitomi T; Yamaji K; Ishikawa H; Ohnishi Y
Japanese Journal of Ophthalmology 2002; 46: 401-405
